Fig. 1: 5-year clinical data update from all patients. | Nature Communications

Fig. 1: 5-year clinical data update from all patients.

From: Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma

Fig. 1: 5-year clinical data update from all patients.

Kaplan–Meier curve of A the progression-free survival, B overall survival, C duration of response for all patient achieving an objective response (partial response (PR) or complete response (CR)), D duration of response for patients receiving either PR or CR, and E a swimmer plot showing the duration of response for the IDO/PD-L1 vaccine and nivolumab and for the next line of treatment.

Back to article page